Minimally Invasive Esophageal Cancer Surgery.
JS Peng, M Kukar, GN Mann… - Surgical oncology clinics …, 2019 - europepmc.org
Minimally Invasive Esophageal Cancer Surgery. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
Minimally invasive Ivor Lewis esophagectomy with linear stapled anastomosis associated with low leak and stricture rates
M Kukar, K Ben-David, JS Peng, K Attwood… - Journal of …, 2020 - Springer
Background Minimally invasive foregut surgery is increasingly performed for both benign
and malignant diseases. We present a retrospective series of patients who underwent …
and malignant diseases. We present a retrospective series of patients who underwent …
Diagnostic laparoscopy prior to neoadjuvant therapy in pancreatic cancer is high yield: an analysis of outcomes and costs
JS Peng, J Mino, R Monteiro, G Morris-Stiff… - Journal of …, 2017 - Springer
Background There is currently no standardized regimen for management of borderline
resectable pancreatic cancer (BRPC), and treatment includes varying sequences of surgery …
resectable pancreatic cancer (BRPC), and treatment includes varying sequences of surgery …
Adjuvant chemotherapy after neoadjuvant chemotherapy for pancreatic cancer is associated with improved survival for patients with low-risk pathology
EJ Olecki, KA Stahl, MB Torres, JS Peng… - Annals of surgical …, 2021 - Springer
Background With limited evidence, the benefit of adjuvant chemotherapy (AT) after
completion of neoadjuvant chemotherapy (NT) and surgical resection for patients with …
completion of neoadjuvant chemotherapy (NT) and surgical resection for patients with …
Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
JS Peng, J Wey, S Chalikonda, DS Allende… - … & Pancreatic Diseases …, 2019 - Elsevier
Background Previous studies have demonstrated the prognostic significance of pathologic
tumor response in pancreatic adenocarcinoma following neoadjuvant therapy (NAT). The …
tumor response in pancreatic adenocarcinoma following neoadjuvant therapy (NAT). The …
[HTML][HTML] Gastric cancer treatments and survival trends in the United States
KA Stahl, EJ Olecki, ME Dixon, JS Peng, MB Torres… - Current …, 2020 - mdpi.com
Gastric cancer is the third most common cause of cancer deaths worldwide. Despite
evidence-based recommendation for treatment, the current treatment patterns for all stages …
evidence-based recommendation for treatment, the current treatment patterns for all stages …
Albumin‐bilirubin score is superior to platelet‐albumin‐bilirubin score and model for end‐state liver disease sodium for predicting posthepatectomy liver failure
WG Wong, RA Perez Holguin, AY Tarren… - Journal of Surgical …, 2022 - Wiley Online Library
Background Risk stratification for patients undergoing hepatectomy can be attempted using
established models. This study compares the platelet‐albumin‐bilirubin (PALBI) score with …
established models. This study compares the platelet‐albumin‐bilirubin (PALBI) score with …
[HTML][HTML] Pancreatoduodenectomy after Roux-en-Y gastric bypass: technical considerations and outcomes
JS Peng, R Corcelles, K Choong, M Poturalski… - HPB, 2018 - Elsevier
Background Patients with altered anatomy due to Roux-en-Y gastric bypass (RYGB) present
unique diagnostic and therapeutic challenges when they present with periampullary …
unique diagnostic and therapeutic challenges when they present with periampullary …
Risk‐stratified analysis of pasireotide for patients undergoing pancreatectomy
JS Peng, D Joyce, M Brady, A Groman… - Journal of surgical …, 2020 - Wiley Online Library
Abstract Background and Objectives Pasireotide was shown in a randomized trial to
decrease the rate of postoperative pancreatic fistula (POPF). However, retrospective series …
decrease the rate of postoperative pancreatic fistula (POPF). However, retrospective series …
Robotic versus thoraco-laparoscopic minimally invasive Ivor Lewis esophagectomy, a matched-pair single-center cohort analysis
K Chouliaras, K Attwood, M Brady… - Diseases of the …, 2023 - academic.oup.com
Minimally invasive esophagectomy (MIE) is becoming more widespread with a documented
improvement in postoperative morbidity based on level I evidence. However, there is a lack …
improvement in postoperative morbidity based on level I evidence. However, there is a lack …